register

News & Trends - Pharmaceuticals

A permanent dent in a big problem: Omico’s CEO Professor Thomas and Oncologist A/Professor Underhill

Health Industry Hub | May 9, 2024 |

Pharma News: Professor David Thomas, CEO of Omico, and Associate Professor Craig Underhill, Medical Oncologist, Albury-Wodonga, joined Health industry Hub to engage in a comprehensive discussion on Australia’s largest cancer genomics program, PrOSPeCT, and the mission of enhanced cancer outcomes.

Professor Thomas elaborated on the vision of PrOSPeCT, highlighting the unique funding model born out of public-private partnerships.

“As the evidence for benefits rises in the experience of individual clinicians, I’ve no doubt that they will come on board. It’s a fundamental cultural change. We’ve had referrals from 700 out of the 800 oncologists in this country, which speaks to the fact that they’re aware and a lot of them are making it a standard of care. We hope that this trend continues,” explained Professor Thomas.

Associate Professor Underhill underscored the crucial role of PrOSPeCT in addressing disparities in cancer outcomes between urban and regional Victoria, aligning with his passion for driving equitable access to healthcare. He shared first-hand insights into the challenges facing underserved communities in cancer care and tangible benefits of participating in PrOSPeCT.

“The fantastic thing about PrOSPeCT is it’s working in that networked way, bringing regional sites into the fold,” stated Associate Professor Underhill.

Professor Thomas further elaborated on the synergies between PrOSPeCT and the newly established Precision Care Clinic at Prince of Wales Hospital, while drawing inspiration from international models of cancer genomics programs including the success of the Dutch model.

Concluding the discussion, Professor Thomas outlined key milestones for PrOSPeCT in the short-term, signalling an ongoing commitment to driving enhanced outcomes in cancer care and oncology research.

“I’d like to leave a permanent dent in a big problem,” said Professor Thomas.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the ONLY one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The exclusive leadership and influencer podcasts and vodcasts add huge value to our breaking news coverage. The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. Please click here to subscribe and visit T&Cs here.


Human Resources

The return-to-office debate: Where are we in the pendulum's swing?

The return-to-office debate: Where are we in the pendulum’s swing?

Health Industry Hub | May 24, 2024 |

People & Culture: The evolution of hybrid and flexible workplaces has yielded mixed results across the healthcare sector, with some […]

More


News & Trends - MedTech & Diagnostics

Cardinal Health launches local facility for reprocessing of single-use medical devices

Cardinal Health launches local facility for reprocessing of single-use medical devices

Health Industry Hub | May 24, 2024 |

MedTech & Diagnostics News: Cardinal Health is set to launch a cutting-edge facility in Australia dedicated to the reprocessing of […]

More


Medical

New ophthalmic centre to partner on pharma and medtech clinical trials

New ophthalmic centre to partner on pharma and medtech clinical trials

Health Industry Hub | May 24, 2024 |

Medical: The Victorian Deputy Premier and Minister for Medical Research, the Hon Ben Carroll, has launched a cutting-edge ophthalmic clinical […]

More


News & Trends - Pharmaceuticals

Private sector, government and academia gather to tackle barriers in vaccine value chain

Private sector, government and academia gather to tackle barriers in vaccine value chain

Health Industry Hub | May 24, 2024 |

Pharma News: An ‘invite only’ vaccine thought leadership event, aimed at addressing gaps in Australia’s vaccine ecosystem and maximising the […]

More


This content is copyright protected. Please subscribe to gain access.